Stay updated with breaking news from Telo Genomic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Telo Genomics Corp. a biotech company developing the industry's leading telomere technology platform with diagnostic and prognostic applications measuring genomic instability in oncology, is...
Telo Genomics Corp. is pleased to announce that it has passed all requirements and received its Certificate of Accreditation of ISO 15189. Importantly, the rigorous ISO 15189 is the...
/PRNewswire/ -- Multiple myeloma is a type of cancer that affects plasma cells, which are a type of white blood cell that produces antibodies to fight...
Telo Genomics Corp. today announced the launch of its TeloViewSMM to clinicians in the United States. Combining molecular biology and artificial intelligence, the diagnostic platform performs...
Toronto, Ontario--(Newsfile Corp. - December 7, 2021) - Telo Genomics Corp. (TSXV: TELO) (the "Company" or "TELO") is pleased to announce its successful uplisting from the OTC Pink Sheets to the OTCQB®